|

18F-Fluciclovine Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: (1r, 3r)-1-amino-3[18F] fluorocyclobutane-1-carboxylic acid, 18F-FACBC, Axumin

Pipeline

Early 1: 1Phase 1: 3Phase 2: 1

Top Sponsors

  • Baptist Health South Florida3
  • Children's Hospital of Philadelphia1
  • Brigham and Women's Hospital1

Indications

  • Cancer5
  • Brain Cancer3
  • Brain Metastases3
  • Brain Metastases, Adult2
  • Metastatic Prostate Neuroendocrine Carcinoma1

Miami, Florida3 trials

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Miami Cancer Institute

Phase 1
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Miami Cancer Institute

Phase 1
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

Miami Cancer Institute at Baptist Health South Florida

Phase 2

Boston, Massachusetts1 trial

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Dana Farber Cancer Institute

Phase 1

Philadelphia, Pennsylvania1 trial

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

The Children s Hospital of Philadelphia

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.